ATEROSKLEROZ KELIB CHIQISHIDA METABOLITIK SINDROMLARI BIOKIMYOSI

Yusupova Dilroz Hamdam qizi

Authors

Yusupova Dilroz Hamdam qizi Author

Abstract

Ateroskleroz va metabolik sindrom zamonaviy tibbiyotda yurak-qon tomir kasalliklarining yetakchi xavf omillari sifatida tan olinmoqda. Ushbu maqolada metabolik sindromga xos bo‘lgan insulin rezistensiyasi, dislipidemiya, yallig‘lanish reaktsiyalari, oksidlovchi stress va arterial gipertenziyaning ateroskleroz rivojlanishiga ta’siri biokimyoviy nuqtai nazardan tahlil qilindi. Metabolik va molekulyar mexanizmlar, asosiy fermentlar va signal yo‘llari detallashtirildi. Tadqiqot natijalari metabolik sindromni erta aniqlash va aterosklerozning oldini olish strategiyalarini takomillashtirish imkonini beradi.

References

1. Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference. Circulation, 109(3), 433-438.

2. Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868-874.

3. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860-867.

4. Chait, A., & Bornfeldt, K. E. (2009). Diabetes and atherosclerosis: Is there a role for hyperglycemia? Journal of Lipid Research, 50(Suppl), S335-S339.

5. Ross, R. (1999). Atherosclerosis—An inflammatory disease. New England Journal of Medicine, 340(2), 115-126.

6. Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature, 414(6865), 782-787.